Rivaroxaban Accord
The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.
Name | Rivaroxaban Accord |
---|---|
Active Substance | rivaroksaban |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
ATC Code | B01AF01 |
Summary of product characteristics (SmPC), labelling and package leaflet (PL) | download |
Link to the European Medicines Agency's (EMA) product information | download |
Link to the European Commission's (EC) decisions | download |
Educational materials for healthcare professionals |
Vodič za liječnike s informacijama o primjeni rivaroksabana, verzija 1 |
Educational materials for patients / caregivers |
Kartica s upozorenjima za bolesnika Rivaroksaban Accord |